本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

4D Molecular Therapeutics

2.89
-0.3950-12.04%
盘后2.910.0250+0.87%18:39 EDT
成交量:55.62万
成交额:163.75万
市值:1.34亿
市盈率:-0.97
高:3.12
开:3.12
低:2.88
收:3.28
数据加载中...
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

重要事件披露

Form 8-K - Current report
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]